Filtered By:
Condition: Pneumonia
Vaccination: Vaccines

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1604 results found since Jan 2013.

Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS
Semin Immunol. 2023 Sep 15;70:101842. doi: 10.1016/j.smim.2023.101842. Online ahead of print.ABSTRACTVaccines are among the greatest inventions in medicine, leading to the elimination or control of numerous diseases, including smallpox, polio, measles, rubella, and, most recently, COVID-19. Yet, the effectiveness of vaccines varies among individuals. In fact, while some recipients mount a robust response to vaccination that protects them from the disease, others fail to respond. Multiple clinical and epidemiological factors contribute to this heterogeneity in responsiveness. Systems immunology studies fueled by advances in...
Source: Seminars in Immunology - September 17, 2023 Category: Allergy & Immunology Authors: Djamel Nehar-Belaid Mark Sokolowski Sathyabaarathi Ravichandran Jacques Banchereau Damien Chaussabel Duygu Ucar Source Type: research

Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022
MMWR Morb Mortal Wkly Rep. 2023 Sep 8;72(36):979-984. doi: 10.15585/mmwr.mm7236a2.ABSTRACTDespite the availability of effective vaccines against pneumococcal disease, pneumococcus is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations among U.S. adults per year. In addition, approximately 30,000 invasive pneumococcal disease (IPD) cases and 3,000 IPD deaths occur among U.S. adults each year. Previous health care provider surveys identified gaps in provider knowledge about and understanding of the adult pneumococcal vaccine recommendations, and pneumococcal vaccine coverage remains suboptim...
Source: MMWR Morb Mortal Wkl... - September 7, 2023 Category: Epidemiology Authors: Rebecca Kahn Lindsay Zielinski Amber Gedlinske Natoshia M Askelson Christine Petersen Andrew M Parker Courtney A Gidengil Alison P Albert Angela J Jiles Megan C Lindley Miwako Kobayashi Aaron M Scherer Source Type: research

COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development
Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023.ABSTRACTThe world is presently in crisis facing an outbreak of a health-threatening microorganism known as COVID-19, responsible for causing uncommon viral pneumonia in humans. The virus was first reported in Wuhan, China, in early December 2019, and it quickly became a global concern due to the pandemic. Challenges in this regard have been compounded by the emergence of several variants such as B.1.1.7, B.1.351, P1, and B.1.617, which show an increase in transmission power and resistance to therapies and vaccines. Ongoing researches are ...
Source: Biomed Res - September 7, 2023 Category: Research Authors: Narjess Bostanghadiri Pardis Ziaeefar Morvarid Golrokh Mofrad Parsa Yousefzadeh Ali Hashemi Davood Darban-Sarokhalil Source Type: research

Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022
MMWR Morb Mortal Wkly Rep. 2023 Sep 8;72(36):979-984. doi: 10.15585/mmwr.mm7236a2.ABSTRACTDespite the availability of effective vaccines against pneumococcal disease, pneumococcus is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations among U.S. adults per year. In addition, approximately 30,000 invasive pneumococcal disease (IPD) cases and 3,000 IPD deaths occur among U.S. adults each year. Previous health care provider surveys identified gaps in provider knowledge about and understanding of the adult pneumococcal vaccine recommendations, and pneumococcal vaccine coverage remains suboptim...
Source: MMWR Morb Mortal Wkl... - September 7, 2023 Category: Epidemiology Authors: Rebecca Kahn Lindsay Zielinski Amber Gedlinske Natoshia M Askelson Christine Petersen Andrew M Parker Courtney A Gidengil Alison P Albert Angela J Jiles Megan C Lindley Miwako Kobayashi Aaron M Scherer Source Type: research

COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development
Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023.ABSTRACTThe world is presently in crisis facing an outbreak of a health-threatening microorganism known as COVID-19, responsible for causing uncommon viral pneumonia in humans. The virus was first reported in Wuhan, China, in early December 2019, and it quickly became a global concern due to the pandemic. Challenges in this regard have been compounded by the emergence of several variants such as B.1.1.7, B.1.351, P1, and B.1.617, which show an increase in transmission power and resistance to therapies and vaccines. Ongoing researches are ...
Source: Biomed Res - September 7, 2023 Category: Research Authors: Narjess Bostanghadiri Pardis Ziaeefar Morvarid Golrokh Mofrad Parsa Yousefzadeh Ali Hashemi Davood Darban-Sarokhalil Source Type: research

The role of pneumococcal vaccination in reducing the cardiovascular risk of cardiac patients: opinion of experts of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society
Kardiol Pol. 2023 Sep 3. doi: 10.33963/v.kp.96718. Online ahead of print.ABSTRACTRespiratory diseases have been the fourth most common cause of death in Poland in recent years. Respiratory infection, especially pneumonia, can lead to exacerbation of chronic cardiovascular disease. Streptococcus pneumoniae is the most common bacterial pathogen causing community-acquired pneumonia. Pneumococci are also the most common pathogen complicating the course of influenza virus infection. Pneumonia, especially invasive pneumococcal disease, is associated with the risk of death in the course of respiratory failure or sepsis and also w...
Source: Kardiologia Polska - September 3, 2023 Category: Cardiology Authors: Artur Mamcarz Marcin We łnicki Jaros ław Drożdż Marcin Grabowski Piotr Jankowski Ernest Kuchar Przemys ław Leszek Przemys ław Mitkowski Jacek Wysocki Source Type: research